Why is Torrent Pharma falling/rising?

As of 04-Jul, Torrent Pharmaceuticals Ltd. is experiencing a price increase, currently at 3,368.00, reflecting a rise of 27.1 points or 0.81%. The stock has shown a positive trend today, outperforming its sector by 0.3% and reversing a two-day decline. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward momentum. Additionally, the stock has demonstrated solid performance over the past month with a return of 7.62%, and it has consistently outperformed the broader market over the last year, achieving a return of 17.31%. The company has maintained high management efficiency, evidenced by a return on capital employed (ROCE) of 22.33%, and has reported positive results for the last seven consecutive quarters, contributing to investor confidence.
In the broader market context, Torrent Pharmaceuticals has outperformed the Sensex in the short term, with a 1-week return of -0.21% compared to the Sensex's -0.74%. This indicates that while the stock has faced some recent volatility, it remains resilient relative to the market. The rising investor participation, with a delivery volume increase of 17.62% against the 5-day average, further supports the stock's upward movement. The company's strong fundamentals, including a low debt-to-EBITDA ratio and high institutional holdings, suggest that it is well-positioned for continued growth, despite the fluctuations in the market.